Home » Topics » BioWorld Science

BioWorld Science
RSS

Pivot plans IND filing to begin clinical trials with PVT-005

June 27, 2018

Aclaris initiates phase II trial of ATI-501 for alopecia totalis and alopecia universalis

June 27, 2018

Ensemble Therapeutics divulges IDO-1 inhibitors

June 27, 2018

Fraunhofer-Gesellschaft describes new bacterial glutaminyl cyclase inhibitors

June 27, 2018

Arcus Biosciences, Infinity Pharmaceuticals collaborate on studies of triple combination therapies

June 27, 2018

Apellis initiates phase III trial of APL-2 in PNH

June 27, 2018

Chugai describes OWL-833, an orally active non-peptide GLP-1 receptor agonist

June 27, 2018

In vivo evaluation of PD-L1-targeted PET imaging agent [64Cu]DK222

June 27, 2018

FDA approves Zemdri for cUTI, but issues CRL for bloodstream infections

June 27, 2018

Phase II trial evaluates antimalarial activity of single-dose DSM-265

June 27, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...